share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Apr 4 08:09

Gainers

  • Tevogen Bio Holdings (NASDAQ:TVGN) stock rose 85.5% to $4.86 during Thursday's pre-market session. The market value of their outstanding shares is at $800.0 million.
  • Candel Therapeutics (NASDAQ:CADL) shares rose 27.97% to $2.15. The company's market cap stands at $63.0 million.
  • Healthcare Triangle (NASDAQ:HCTI) stock rose 23.56% to $2.36. The company's market cap stands at $10.9 million.
  • SINTX Techs (NASDAQ:SINT) stock increased by 19.56% to $0.03. The market value of their outstanding shares is at $1.4 million.
  • Addex Therapeutics (NASDAQ:ADXN) shares increased by 16.84% to $18.0. The company's market cap stands at $19.0 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) shares moved upwards by 16.16% to $0.54. The company's market cap stands at $9.6 million.

Losers

  • Telesis Bio (NASDAQ:TBIO) stock fell 11.8% to $0.42 during Thursday's pre-market session. The company's market cap stands at $12.6 million.
  • Achilles Therapeutics (NASDAQ:ACHL) stock declined by 10.0% to $1.08. The market value of their outstanding shares is at $44.0 million. As per the press release, Q4 earnings came out today.
  • OneMedNet (NASDAQ:ONMD) shares declined by 8.22% to $0.97. The market value of their outstanding shares is at $31.3 million.
  • Aprea Therapeutics (NASDAQ:APRE) shares decreased by 7.05% to $6.2. The market value of their outstanding shares is at $23.1 million.
  • Qilian Intl Hldg Gr (NASDAQ:QLI) shares decreased by 5.94% to $0.66. The company's market cap stands at $23.5 million.
  • Helius Medical Tech (NASDAQ:HSDT) stock declined by 5.87% to $6.1. The company's market cap stands at $5.4 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment